Table 3.
OR* (95% CI) | aOR*,† (95% CI) | |
---|---|---|
Primary outcomes | ||
CXR | 1.29 (1.05–1.59)‡ | 1.54 (1.24–1.91)‡ |
Nebulized treatments (All) | 0.89 (0.72–1.11) | 0.92 (0.73–1.16) |
Albuterol | 0.91 (0.73–1.13) | 0.92 (0.73–1.16) |
Ipratropium | 0.97 (0.63–1.49) | 1.09 (0.68–1.73) |
Racemic epinephrine | 0.77 (0.40–1.46) | 0.96 (0.50–1.86) |
Secondary outcomes | ||
Laboratory tests | ||
CBC | 1.24 (0.90–1.73) | 1.75 (1.23–2.48)‡ |
Renal panel | 0.77 (0.40–1.51) | 1.05 (0.53–2.08) |
Viral assays | 1.01 (0.70–1.46) | 1.26 (0.86–1.84) |
Blood culture | 1.18 (0.85–1.65) | 1.65 (1.16–2.36)‡ |
Steroids | 0.71 (0.44–1.13) | 0.70 (0.43–1.17) |
Antibiotics | ||
ED | 1.13 (0.75–1.70) | 1.15 (0.76–1.72) |
Discharge | 1.16 (0.89–1.51) | 1.12 (0.86–1.46) |
Disposition | ||
Admitted | 0.80 (0.65–0.99)‡ | 1.03 (0.82–1.31) |
ICU admission | 0.98 (0.56–1.71) | 1.25 (0.70–2.24) |
aOR indicates adjusted odds ratio; CBC, complete blood count; CI, confidence interval; ICU, intensive care unit; OR, odds ratio; CXR, chest x-ray; and ED, emergency department.
English speakers were used at the referent group.
Odds ratio after adjusting for age, triage level, prior visit, and accounting for attending physician correlation.
P value ≤ .05.